Cholinesterase inhibitors in Alzheimer's disease: a consensus view on managing treatment failure

Author： Emre Murat   Farlow Martin   Bullock Roger   Gauthier Serge   Grossberg George   Potkin Steven G  

Publisher： Informa Healthcare

ISSN： 1473-4885

Source： Primary Care Psychiatry, Vol.9, Iss.1, 2004-01, pp. : 29-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholinesterase inhibitors in Alzheimer’’s disease: sooner or later or both?

By Kerwin Robert  

Future Neurology, Vol. 1, Iss. 6, 2006-11 ,pp. : 737-740

Future Medicine

Access to resources Recommend Favorite

"Value for money" in treating Alzheimer's disease with the new cholinesterase inhibitors

By Shah Ajit   Jenkins Rachel  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 45-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer’s Disease and Mixed Dementia

By  

Current Alzheimer Research, Vol. 10, Iss. 5, 2013-06 ,pp. : 476-481

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimer's Disease Pharmacogenetics

By  

Current Alzheimer Research, Vol. 4, Iss. 4, 2007-09 ,pp. : 479-500

Bentham Science Publishers

Access to resources Recommend Favorite

Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors

By  

Current Alzheimer Research, Vol. 15, Iss. 11, 2018-09 ,pp. : 1077-1084

Bentham Science Publishers

Access to resources Recommend Favorite